Inmune Bio (INMB) Intangibles (2017 - 2025)
Inmune Bio (INMB) has disclosed Intangibles for 9 consecutive years, with $16.5 million as the latest value for Q1 2025.
- Quarterly Intangibles changed 0.0% to $16.5 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $16.5 million through Mar 2025, changed 0.0% year-over-year, with the annual reading at $16.5 million for FY2024, 0.0% changed from the prior year.
- Intangibles hit $16.5 million in Q1 2025 for Inmune Bio, roughly flat from $16.5 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $16.5 million in Q1 2021 to a low of $16.5 million in Q1 2021.
- Historically, Intangibles has averaged $16.5 million across 5 years, with a median of $16.5 million in 2021.
- Biggest YoY gain for Intangibles was 0.0% in 2021; the steepest drop was 0.0% in 2021.
- Year by year, Intangibles stood at $16.5 million in 2021, then changed by 0.0% to $16.5 million in 2022, then changed by 0.0% to $16.5 million in 2023, then changed by 0.0% to $16.5 million in 2024, then changed by 0.0% to $16.5 million in 2025.
- Business Quant data shows Intangibles for INMB at $16.5 million in Q1 2025, $16.5 million in Q4 2024, and $16.5 million in Q3 2024.